References
- Reilly J, Compagnon A, Tournier P, Bastin R, DuSuit H. Les accidents du traitement des fievres typhoides par la chloromycetine. Annal Med (Paris) 1950; 51: 597–629.
- Shenep JL, Flynn PM, Barrett FF, Stidham GL, Westenkirchner DF. Serial quantitation of endotoxemia and bacteremia during therapy for gram-negative bacterial sepsis. J Infect Dis 1988; 157: 565–568.
- Hurley JC. Antibiotic-induced release of endotoxin: a reappraisal. Clin Infect Dis 1992; 15: 840–854.
- Prins JM, van Deventer SJH, Kuijper EJ, Speelman R. Clinical relevance of antibiotic-induced endotoxin release. Antimicrob Agents Chemother 1994; 38: 1211–1218.
- Prins JM, van Agtmael MA, Kuijper EJ, Sander JH, van Deventer SJH, Speelman P. Antibiotic-induced endotoxin release in patients with gram-negative sepsis: a double-blind study comparing imipenem and ceftazidime. J Infect Dis 1995; 172: 886–891.
- Dofferhoff ASM, Nijland JH, de Vries-Hospers HG, Mulder POM, Weits J, Bom VJJ. Effects of different types and combinations of antimicrobial agents on endotoxin release from gram-negative bacteria: an in-vitro and in-vivo study. Scand J Infect Dis 1991; 23: 745–754.
- Rotimi VO, Mokaddas EM, Jamal WY, Khodakhast FB, Verghese TL, Sanyal SC. Susceptibility of 497 clinical isolates of Gram-negative anaerobes to trovafloxacin and eight other antibiotics. J Chemother 1999; 11: 349–356.
- Schiro DD, Aldridge KE. Broth micro-dilution suscepti-bility testing of anaerobic bacteria. In: Isenbery HD, ed. Clinical Microbiology Procedure Handbook, Washington D. C.: America Society for Microbiology Publication, 1992: 5.55-6.17.
- Morrison DC, Danner RL, Dinarello CA, et al. Bacterial endotoxins and pathogenesis of Gram-negative infections: cur-rent status and future direction. J Endot Res 1994; 1: 71–83.
- Rotimi VO, Verghese TL, Al-Sweih NA, Khodakhast FB, Ahmed K. Influence of five antianaerobic antibiotics on endotoxin liberation by Gram-negative anaerobes. J Chemother 2000; 12: 40–47.
- Shenep JL, Barton RP, Mogan KA. Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis. J Infect Dis 1985; 151: 1012–1018.
- Cohen J, McConnel JS. Antibiotic-induced endotoxin release. Lancet 1985; ii: 1069–1070
- Tauber MG, Shibi AM, Hackbarth CJ, Larrick JW, Sande MA. Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits. J Infect Dis 1987; 156: 456–461.
- Dofferhoff ASM, Esselink MT, de Vries-Hospers HG, van Zanten A, Weits J, Vallenga E. The release of endotoxin from antibiotic-treated Escherichia coli and production of tumor necrosis factor by human monocytes. J Antimicrob Chemother 1993; 31: 373–384.
- Friedland IR, Jafari H, Ehrett S. et al. Comparison of endotoxin release by different antimicrobial agents and the effect of inflammation in experimental Escherichia coli meningitis. J Infect Dis 1993; 168: 657–662.
- Buijs J, Dofferhoff ASM. Antibiotic-induced endotoxin releases is type, dose and dosing schedule dependent. Presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL. 1994; Abstract A97.
- Mattsby-Baltzer I, Lindgren K, Lindholm B, Edebo L. Endotoxin shedding by enterobacteria: free and cell-bound endotoxins differ in Limulus activity. Infect Immun 1991; 59: 689–695.
- Van de Berg C, de Neeling AJ, Schot CS, Hustinx WNM, Werner J, de Wildt DJ. Delayed antibiotic-induced lysis of Escherichia coli in vitro is correlated with enhancement of LPS release. Scand J Infect Dis 1992; 24: 619–627.
- Bartlett JG. Infections caused by anaerobic bacteria. In: Gorbach SL, Bartlett JG, Blacklow NR (eds), Infectious Diseases, WB Saunders Company, Philadelphia, 1992: 1555-1568.
- Nitsche D, Schulze C, Oesser S, Dalhoff A, Sack M. Impact of different classes of antimicrobial agents on plasma endotoxin activity. Arch Surg 1996; 131: 192–199.
- Jackson JJ, Kropp H. Beta-lactam antibiotic release of free endotoxin: in vitro comparison of penicillin-binding pro-tein (PBP) 2-specific imipenem and PBP 3-specific cef-tazidime. J Infect Dis 1992; 165: 1033-1041.
- Crosby HA, Sion JF, Penn CW, Elliott TSJ. Antibiotic-induced release of endotoxin from bacteria in vitro. J Med Microbiol 1994; 40: 23–30.
- Rogers JD, Meisinger MAP, Ferber F, Calandra GB Demetriades JL, Bland JA. Pharmacokinetics of imipenem and cilastatin in volunteers. Rev Infect Dis 1985; 7 (suppl 3): 435-446.
- Craig WA, Ebert SC. Killing and regrowth of bacteria in vitro: a review. Scand J Infect Dis 1991; 74 (Suppl): 63-70.